GenetiSure Dx Postnatal Assay
K号: K163367 · 2017-08-11
广告
决定日期2017-08-11
产品代码PFX
咨询委员会抱歉，您提供的信息不完整，无法进行翻译。请提供完整的医疗设备监管文本，以便我能够进行准确的翻译。
决定实质等同
器械摘要
GenetiSure Dx Postnatal Assay is the device name listed in this FDA 510(k) record. The listed applicant is Agilent Technologies, Inc.. It received FDA 510(k) clearance on 2017-08-11 under 510(k) number K163367. The device is classified under product code PFX. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.
常见问题
What is the GenetiSure Dx Postnatal Assay?
GenetiSure Dx Postnatal Assay is a medical device that received FDA 510(k) clearance on 2017-08-11. The listed applicant is Agilent Technologies, Inc.. The 510(k) number is K163367.
When did GenetiSure Dx Postnatal Assay receive FDA 510(k) clearance?
GenetiSure Dx Postnatal Assay received FDA 510(k) clearance on 2017-08-11, under 510(k) number K163367.
Who is the listed applicant for GenetiSure Dx Postnatal Assay?
The FDA 510(k) record lists Agilent Technologies, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for GenetiSure Dx Postnatal Assay?
The FDA product code for GenetiSure Dx Postnatal Assay is PFX.
相关临床试验
关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。
官方来源
在 FDA 数据库中查看 →数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。
广告